News

Sanofi to Buy Vaccine Developer Vicebio for Up to $1.6 Billion
The deal seeks to strengthen the drugmaker’s portfolio of respiratory vaccines and help it move on from pipeline setbacks.
Upcoming IPOs: Five Fresh Issues Hit the Market as Investor Appetite Grows
Lots of new companies are going public this week. Three main ones are Anthem Biosciences, IndiQube Spaces, and GNG ...
5 Things to Know Before the Stock Market Opens
Stock futures are little changed as investors watch for more earnings and trade developments. Here's what investors need to ...
Magentic Raises $5.5M to Meet Demand for AI-driven Savings in Tariff-hit Supply Chains
Magentic, the AI Agent Platform that hunts and delivers savings across global manufacturing supply chains, today announced a $5.5 million funding round led by Sequoia Capital.
The Manila Times29m
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates
Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that it has entered into a ...
BioSpace42m
Why Countries are Racing to Build mRNA Factories While America Hesitates on Next-Gen Vaccines
In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis continues the discussion on mRNA and srRNA ...